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Abstract
As pharmacological data sets become increasingly large and complex, new visual analysis and filtering programs are needed
to aid their appreciation. One of the most commonly used methods for visualizing biological data is the Venn diagram.
Currently used Venn analysis software often presents multiple problems to biological scientists, in that only a limited
number of simultaneous data sets can be analyzed. An improved appreciation of the connectivity between multiple, highly-
complex datasets is crucial for the next generation of data analysis of genomic and proteomic data streams. We describe the
development of VENNTURE, a program that facilitates visualization of up to six datasets in a user-friendly manner. This
program includes versatile output features, where grouped data points can be easily exported into a spreadsheet. To
demonstrate its unique experimental utility we applied VENNTURE to a highly complex parallel paradigm, i.e. comparison of
multiple G protein-coupled receptor drug dose phosphoproteomic data, in multiple cellular physiological contexts.
VENNTURE was able to reliably and simply dissect six complex data sets into easily identifiable groups for straightforward
analysis and data output. Applied to complex pharmacological datasets, VENNTURE’s improved features and ease of analysis
are much improved over currently available Venn diagram programs. VENNTURE enabled the delineation of highly complex
patterns of dose-dependent G protein-coupled receptor activity and its dependence on physiological cellular contexts. This
study highlights the potential for such a program in fields such as pharmacology, genomics, and bioinformatics.
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Introduction
As our knowledge of the inter-connected complexity of
physiological, cellular and molecular functions expands, there is
an ever increasing need for novel methods to study multiple
datasets simultaneously. One of the most common methods for
data set analysis is the Venn diagram. These typically consist of
multiple intersecting regions (usually circles), that allow analysis of
all logical relationships between different data sets [1]. With Venn
diagram analysis, the set-unique and set-intersection values can be
easily illustrated for the viewer. For more than three data sets, the
structure of the sets and intersections can however start to become
problematical from a visualization standpoint, i.e. usable repre-
sentation of all overlapping regions and Venn symmetry can often
be lost. Venn himself generated visualization platforms that
facilitate simultaneous analysis of higher numbers of sets, by using
additional successive ellipses that intersect with the primary circles.
He also gave a construction for Venn diagrams for any number of
sets, where each successive curve delimiting a set is interleaved
with previous curves, starting with the 3-circle diagram [1]. A. W.
F. Edwards also developed elegant display methods for diagrams
composed of higher numbers of sets that feature some interesting
symmetries [2]. The Edwards Venn diagram was achieved by
projecting the classical circular Venn diagram onto a sphere. In
this format, three sets are represented by taking three hemispheres
at right angles to each other, while a fourth set can be represented
by taking a curve similar to the seam on a tennis ball which
undulates around the sphere equator. The resulting sets can then
be projected back to a flat plane, generating ‘cogwheel’ diagrams
with increasing numbers of teeth.
Numerous online Venn diagram programs are currently
available to create a simultaneous visual interpretation of large
amounts of biological data with up to four independent datasets,
examples of such programs include Pangloss Venn diagram
generator (http://www.pangloss.com/seidel/Protocols/venn4.cgi)
and Venny (http://bioinfogp.cnb.csic.es/tools/venny/index.
html). These programs provide an invaluable resource, but are
often designed primarily to generate images rather than assist
facile output and attachment of additional identifiers to the data.
Venn diagram programs can require laborious transfer of
information from spreadsheets into text files before inputting.
With the use of ever more complex datasets, this data handling can
become a serious, time-limiting issue. In addition to input
limitations, modern Venn diagram programs, such as the excellent
program Venny, are capable of comparing only a maximum of
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(http://theory.cs.uvic.ca/euler/DrawVenn/) and BioVenn [4] are
also useful programs that instead allow the generation of area-
proportional venn set analyses. Programs such as GeneVenn
(http://www.bioinformatics.org/gvenn/) and VennMaster
(http://www.informatik.uni-ulm.de/ni/staff/HKestler/vennhyp/
) have the additional feature of linking genes within each group to
related information in the NCBI Entrez Nucleotide database or
the Gene Ontology database, but these programs are still limited
to the analysis of two or three gene lists [5,6]. GeneSpring (http://
www.strandgenomics.com/GeneSpring) and SilicoCyte (http://
www.cytogenomic.com/silicocyte.htm) are software packages spe-
cifically designed to analyze large volumes of microarray data with
several visualizations, including Venn diagrams. However both of
these programs are also limited in both the number of data sets
and the variety of studies for which they can be employed. The
program we have developed, VENNTURE, provides a simple
interface for Edwards Venn diagram generation. It is designed
with the following novel attributes in mind, i.e. ease of data
importation and exportation, compatibility with commonly-used
windows-based programs and a sufficient flexibility to facilitate the
analysis of two to six sets of any length of dataset.
An ideal practical application for the simultaneous Venn
analysis of more than four discrete sets is the investigation of
concentration-dependent effects in log dose-response curve rela-
tionships generated from drug/ligand-mediated transmembrane
receptor activation. The ligand-mediated log-dose response curve
(LDRC) has long been one of the fundamental experimental
paradigms in pharmacology. Such simple experiments allow the
quantitative and qualitative investigation of ligand-mediated cell
signaling effects. For example, a simple LDRC usually consists of a
control ligand response effect (i.e. no drug/ligand added) and
normally five logarithmically-increasing ligand/drug doses, each
generating increasing or decreasing cellular responses. Ideally this
drug/ligand dose range should encompass both the half-maximal
effect of the drug/ligand and also the maximal cellular response.
In recent times however, receptor research especially in the field of
G protein-coupled receptors (GPCRs), has indicated potential
limitations in LDRCs, i.e. they only identify the dose-dependent
variation of signal generation for one output index, e.g. intracel-
lular calcium mobilization. This single function output is now
considered a serious limitation for GPCR analysis, as they are now
known to activate many more signaling pathways simultaneously
than previously thought [7–10]. Recent evidence has also
suggested that distinct isomeric structures of the same GPCR,
stabilized by differential intracellular protein interactions, can
mediate qualitatively distinct signaling responses to different
ligands [8,9,11]. It is therefore possible that for a given LDRC
profile, distinct receptor isomers could differentially contribute to
the creation of the various dose-related responses [8,12]. In
addition to our current adjustments to hypotheses of GPCR
function, our historical appreciation of the cellular signaling
pathways activated by GPCRs as linear and discrete entities, has
now largely been superseded by a broader posit that resultant
molecular signaling functions are the products of highly-intercon-
nected molecular (gene or protein) network interactions [7–9,13].
The functional output therefore of cellular signaling cascades may
be best appreciated by studying the interaction and convergence of
multiple pathways and signaling paradigms. Indeed, investigation
and profiling of GPCR signaling pathways is now often performed
at both the genomic and proteomic levels. These two techniques
often can generate large volumes of data, especially with the
introduction of paradigms involving multiple ligand structures,
multiple drug doses and stimulation time-points as well as the use
of diverse cellular receptor contexts [11,14,15]. This final aspect
described, i.e. cellular receptor context, is emerging as a critical
factor in analyzing receptor signaling function. We have recently
demonstrated a novel cellular receptor context model, generated
by molecular adaptive changes to a mild long-term oxidative stress
(termed ‘chronic minimal peroxide-CMP’), which mimics multiple
aspects of the neuronal aging process [14]. Using this model, we
demonstrated that multiple receptor-mediated processes are
profoundly altered at both the cell signaling and the genomic
response level. The ability to appreciate numerous functional
aspects and nuances in GPCR signaling is likely to assist with the
development of more cellular context-specific and signal-selective
GPCR-based therapeutics [7,8]. GPCR-based therapeutic design
has been one of the most important advances in clinical
pharmacology, as nearly 60% of all current drugs are GPCR-
targeted [16]. Therefore the ability to analyze multiple (up to 6)
complex datasets from LDRC experiments, in parallel, may
greatly assist our future understanding of the complexity of
biological receptor signaling systems across multiple cellular
contexts. In this study, we have employed our newly developed
software program, to not only identify the multiple subtleties of
basic dose-dependent GPCR signaling, but also to illuminate the
importance of considering cellular context with respect to
functional GPCR signaling outputs.
Methods
Cell Culture
Human neuroblastoma SH-SY5Y cells were used to generate
the biological data employed in this study. Passage 5–10 SH-SY5Y
cells were obtained from the American Type Culture Collection
(ATCC: http://www.atcc.org/) and cultured according to ATCC
protocols. SH-SY5Y cells were maintained in medium that was a
1:1 mixture of advanced minimal essential medium (MEM) and F-
12+ GlutaMAX-1 supplemented with 10% fetal bovine serum and
1% penicillin/streptomycin (Gibco-BRL), as described previously
[14].
Cell Stimulation Protocols
SH-SY5Y cells were allowed to grow in monolayers and were
serum-deprived for 16 hours prior to experimental protocols. Cell
monolayers of SH-SY5Y cells, at approximately 75% confluence,
were stimulated with various doses, 10 nM, 100 nM, 1 mM,
10 mM or 100 mM, of the muscarinic G protein-coupled receptor
agonist, acetyl-b-methylcholine chloride (MeCh: Sigma Aldrich, St
Louis MO) for fifteen minutes before removal of the stimulating
ligand by aspiration. Cell monolayers were then washed twice in
ice-cold phosphate-buffered saline (PBS). Cells were then manually
removed from the plates by scraping followed by centrifugal
pelleting (10006g, 5 minutes at 4uC). Recovered cell pellets were
suspended in freshly prepared 8 M urea (Invitrogen, Carlsbad CA)
with 50 mM NH4HCO3 (Fluka) and were completely disrupted
using a Sonic Dismembrator (Model 100, Thermo Fisher
Scientific). Protein lysate concentrations were subsequently deter-
mined by a BCA (bisinchoninic acid) protein assay kit (Thermo
Fisher Scientific). Extracted proteins were immediately processed
for subsequent phosphoprotein isolation and mass spectrometric
analysis.
Cellular Context Modification
To modify the cellular context of the SH-SY5Y cells,
experimental ligand stimulation with MeCh was performed in
both normal (control state) serum-deprived SH-SY5Y cells and
also SH-SY5Y cells exposed to seven days of incubation with
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exposure, simulates in several aspects, long-term minimal oxida-
tive cell stress. This peroxide exposure paradigm that we have
previously described as ‘chronic minimal peroxide’ (CMP), can
induce multidimensional genomic and proteomic alterations that
can generate a partial mimetic of aged neuronal tissues. In
addition, this CMP treatment has also been shown to significantly
alter ligand-mediated drug effects [14]. Whole-cell lysates were
then produced as described in the previous section and phospho-
proteins were purified using immobilized metal affinity chroma-
tography and identified using a ThermoFinnigan LXQ tandem
mass spectrometer.
Western Blotting
To identify specific protein expression alterations in response to
the CMP treatment, as well as to verify MeCh-induced protein
phosphorylation targets, SH-SY5Y whole-cell extracts were first
quantified using BCA reagent (ThermoScientific, Rockford IL)
before resolution with SDS-PAGE and electrotransfer to PVDF
membranes (Perkin Elmer, Waltham MA). Membranes were
blocked for western blots, as described previously [13] and
primary antibody immune-reactive complexes were identified
using alkaline phosphatase-conjugated secondary antisera (Sigma
Aldrich) with enzyme-linked chemifluorescence (GE Healthcare,
Piscataway NJ) and quantified with a Typhoon 9410 variable-
mode phosphorimager. Anti-lamin-A (LMNA), anti-calmodulin
(CALM1), anti-calreticulin (CALR) sera were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA) and anti-G protein-coupled
receptor kinase interacting ArfGAP 2 (GIT2) sera was obtained
from NeuroMab (San Jose, CA). Anti-active, and anti-non-active
extracellular signal-regulated kinase 1/2 (ERK1/2), anti-G
protein-coupled receptor kinase interacting ArfGAP 1 (GIT1) sera
were obtained from Cell Signaling Technology (Danvers, MA).
ERK1/2 activation log dose-response relationships and any
subsequent statistical analysis (Student’s t-test) were assessed using
GraphPad Prism version 5.02.
Immunoprecipitation Protocols
SH-SY5Y cells, either non-stimulated or MeCh-stimulated,
were prepared for immunopurification of phosphorylation target
proteins as follows. MeCh-containing media (post fifteen minute
stimulation) was aspirated from the stimulated cell monolayers,
which were then washed twice in ice-cold phosphate-buffered
saline before lysis in an NP-40-based lysis buffer as described
previously [17]. Cell lysates were prepared by agitation for 20
minutes at 4uC before centrifugal clarification (14000 rpm/10
minutes/4uC). Normalized supernatant protein lysates were pre-
cleared using protein A/G pre-conjugated agarose beads (EMD
Chemicals, Gibbstown NJ). Specific anti-protein sera (10 mg total),
plus 30 mL of protein A/G pre-conjugated agarose beads, were
then added to the pre-cleared supernatants with agitation at 4uC
for four hours. Immunoprecipitates were collected via centrifuga-
tion, washed in the NP-40-based buffer and proteins were eluted in
30 mL Laemmli (8% SDS) buffer. Samples were then processed for
western blotting. Specific antisera employed for immunoprecipi-
tation studies were obtained from the following sources: anti- G
protein-coupled receptor kinase interacting ArfGAP 1 (GIT1) and
anti-p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1) was
obtained from Cell Signaling Technology (Danvers, MA); anti-G
protein regulated inducer of neurite outgrowth 1 (GPRIN1) and
anti-reticulon 4 (RTN4) were obtained from Abcam (Cambridge,
MA); anti-Grb2-associated binding protein 2 (GAB2) and anti-
microtubule-associated protein 2 (MAP2) were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA); anti-phosphoserine/
phosphothreonine antisera were obtained from Millipore (Bill-
erica, MA).
Mass Spectrometry-targeted Primary Protein Extraction
Proteins were extracted from SH-SY5Y cell pellets for mass
spectrometry analysis as follows. In brief, samples were initially
reduced in 12.5 mM tris(2-carboxyethyl) phosphine (Sigma) at
room temperature (RT) for 1 h, then alkylated with 25 mM
iodoacetamide (Sigma) at RT for 30 min with protection from
ambient light. The reaction was then quenched with incubation in
15 mM dithiothreitol (Sigma) at RT for 15 min. Resultant protein
extracts were diluted in 50 mM NH4HCO3 to a final concentra-
tion of 1 M urea and were digested using sequencing-grade trypsin
(Promega) at a 1:75 (trypsin/protein, w/w, 37uC) ratio. After a
sixteen hour digestion, formic acid (Fluka) was added to a final
concentration of 0.5% (v/v). Peptide samples were then desalted
using Sep-Pak Vac C18 cartridges (3cc/200 mg, Waters). Sep-Pak
cartridges were then washed with 3 mL of acetonitrile (ACN,
Thermo Fisher Scientific) and equilibrated with 3 mL of 0.1%
formic acid. Cartridges were loaded with peptides (1.5 mg per
cartridge), then washed with 6 mL of 0.1% formic acid. Peptides
were subsequently eluted with 1 mL of 80% ACN/0.1% formic
acid and dried to below 50 mL using a Savant SpeedVac (Thermo
Fisher Scientific) before further processing and phosphoprotein
purification.
Phosphoprotein Extraction and Purification
All mass spectrometric columns employed were fabricated using
360 mm outer-diameter fused-silica capillaries (Polymicro Tech-
nologies). Phosphoproteins were extracted from general protein
extracts using a modified immobilized metal affinity chromatog-
raphy (IMAC) process using titanium dioxide (TiO2) particles. To
create TiO2 IMAC columns, 150 mm inner-diameter capillary was
cut and one end was placed in Kasil solution (Next Advance,
Averill NY) to allow the solution to enter the capillary to a length
of 3–4 cm by capillary action. Frit formation, to create a stable
compartment to retain the TiO2 resin, was completed using
heating of the packed capillary (16 h, 70uC). The excess frit was
removed (1 cm remaining), then the capillary was packed with
TiO2 particles (Titansphere TiO2,5 mm, GL Sciences) and
suspended in 50% methanol (J.T. Baker). Capillary column
packing, washing, sample loading and elution, were carried out
manually using a controllable nitrogen pressure loader (Next
Advance-model PC 77). The amount of packed TiO2 particles was
measured by weighing the column before and after packing, using
a microbalance (Sartorius Instruments, Goettingen Germany) in
dry laboratory conditions. Approximately 6 cm packing was equal
to 2 mg of particles of TiO2 particles. An analytical C18 column,
with integrated electrospray emitter tip, was prepared on a laser
puller (P2000, Sutter Instruments, Novato CA) with a 75 mm
internal-diameter fused-silica capillary, using a previously devel-
oped protocol [18]. C18 resins (Magic C18, 5 mm, 300 A ˚,
Michrom Bioresources, Auburn CA) were packed to 8.5 cm of the
10.5-cm frit-less capillary column. The resulting C18 capillary
column was used for standard analysis and as the electrospray
interface for liquid chromatography-tandem mass spectrometry
(LC–MS/MS) [19]. To enrich primary extracted peptide samples
for phosphorylated species, the TiO2 capillary column was first
treated with 1% ammonia (Fluka, St. Louis MO) and then with a
modified wash buffer containing, 80% ACN, 2% trifluoroacetic
acid and 1 M glycolic acid (‘ATG’ buffer), for 10 min each at a
1.5-mL/min flow rate using the nitrogen pressure loader. Peptide
samples were mixed 1:1 with the specific ATG buffer and loaded
onto the column at a flow rate of 0.8 mL/min. The loaded amount
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with ATG buffer for 10 min at 1.5 mL/min and then bound
peptides were eluted with 1% ammonia (pH 11.3) for 5 min at
1.5 mL/min and then immediately acidified with 5 mLo f2 %
trifluoroacetic acid (Fluka). All of the samples were prepared as
three replicates from tryptic digestions and were stored at –80uC
until used.
Mass Spectrometric Analysis
LC–MS/MS was performed using an LXQ linear ion-trap mass
spectrometer coupled with a Surveyor LC system (ThermoFisher
Scientific, West Palm Beach FL). Peptide samples were pressure-
loaded onto pre-equilibrated analytical columns with a flow rate of
200–400 nL/min. Capillary tip columns were connected to the
LXQ ion source in the MS system, and reversed-phase
chromatographic separations were carried out using the following
gradient settings: 100% A (0.1% formic acid in water) for 10 min,
0–50% B (0.1% formic acid in 100% ACN) for 100 min, 50–70%
B for 10 min, and 70% B for 5 min. Pump flow rates were
controlled to deliver 200 nL/min to the analytical column. This
flow rate was consistently and reliably achieved by splitting the
pump flow at a 1:1000 ratio. LXQ MS settings were as follows:
spray voltage of 1.6 kV, 1 microscan for MS scans at a maximum
inject time of 10 ms with a mass range of m/z 400–1400, and 3
microscans for MS/MS at a maximum inject time of 100 ms with
automatic mass range. The LXQ was operated in a data-
dependent mode, that is, one MS scan for precursor ions followed
by four data-dependent MS/MS scans for precursor ions above a
threshold ion count of 500 with a normalized collision energy
value of 35%.
MS/MS data processing and database searches were performed
on BioWorks Browser 3.3.1 SP1 (Thermo Fisher Scientific). DTA
files were generated from LC–MS/MS raw files with the following
options applied: precursor ion tolerance of 1.5 amu, group scan 1,
minimum group count 1, minimum ion count 20, and filtering
through charge state analysis. The generated DTA files were
searched against a composite target–decoy database [20]. This
database was composed of human complete proteome (UniProt
release-15.8, with 59,155 protein entries) and its reversed sequence
version with the following criteria: enzyme, trypsin (KR/P); full
enzymatic cleavage; missed cleavage sites, 3; peptide tolerance, 2.0
amu; fragment ion tolerance, 1.0 amu; variable modifications,
carbamidomethylation (+57 Da), methionine oxidation (+16 Da),
and STY phosphorylation (+80 Da); modifications per peptide, 4.
The search result was filtered with Xcorr versus charge state
(Xcorr of 1.5, 2.0, 2.5, and 3.0 for +1, +2, +3, and .+3 charges,
respectively) and delta CN 0.08. To ensure that the false discovery
rate (FDR) of peptide–spectral matches (PSMs) remained below
0.5%, the search results were further filtered with various Sf (Forial
Score) values. An Sf value of 0.60 was used for an FDR of 0.49%
for the overall results. Fragmentation spectra for peptides with
only a single observation and for multiply phosphorylated peptides
were verified through manual inspection according to previously
published protocols [21].
Ligand-mediated Phosphorylation Data Analysis
The baseline presence of phosphoproteins in the serum-
deprived non-stimulated SH-SY5Y cells, as well as the induction
of protein phosphorylation by the fifteen minute stimulation with
10 nM, 100 nM, 1 mM, 10 mM and 100 mM MeCh doses was
assessed in the presence or absence of our applied CMP protocol.
In addition to the primary protein analysis, we performed both
Gene Ontology Analysis using WebGestalt (p#0.05 for specific
GO term groups) (http://bioinfo.vanderbilt.edu/webgestalt/) as
well as canonical signaling pathway analysis using Ingenuity
Pathways Analysis version 8.5 (http://www.ingenuity.com/).
Gene Ontology (GO) term groups are curated functional
annotations for protein activity (http://www.geneontology.org/).
Proteins can be associated with multiple GO term groups after
the generation of empirical data concerning the specific activities
of that protein. Multifunctional proteins such as actin can be
associated with many different GO term annotations, while more
specific proteins are associated with a more narrow range of GO
terms. Using our novel Venn diagram program, VENNTURE,
we were then able to separate the multiple phosphoproteins,
significantly-populated GO terms and significantly-populated
canonical signaling pathways associated with the differing doses
(in control or CMP environments) of MeCh stimulation.
VENNTURE Software Development and Application
VENNTURE was programmed using the Microsoft Founda-
tion Class (MFC) library, written in C++. The resulting MFC
application can be used on any personal computer using any XP
or higher Windows
TM based system. VENNTURE version
1.1.0.2 can be accessed freely at the National Institute on Aging
(http://www.nia.nih.gov). To upload biological data in VENN-
TURE, the data sets must be organized in an Excel
TM
spreadsheet, where each column corresponds to a specific data
set. The first column in any given spreadsheet represents set 1
and the successive columns the additional sets (up to 62 sets for
6-way Edwards diagrams). To upload the data into VENN-
TURE simply requires activation of the ‘Load’ window option
and browsing for the appropriate Excel
TM spreadsheet file (*.xls
or *.xlsx). VENNTURE then automatically searches for multiple
sets within the first sheet of the Excel
TM file. One Excel
TM file
should only contain data columns in the first sheet in the file.
After the appropriate file is loaded, VENNTURE converts the
datasets into strings, and uploads the information into internal
arrays. Once the data has been uploaded, the data strings are
compared to determine overlap and create the appropriate
Edwards Venn diagram display categories. VENNTURE then
draws the appropriate Venn diagram for the number of data sets
contained in the uploaded Excel
TM file. Depending on the
number of datasets uploaded, VENNTURE will draw the
appropriate Edwards Venn diagram variant. The Venn diagram
will then be populated with the categorized data. In addition to
creating the visual Edwards Venn image, VENNTURE simul-
taneously produces an Excel output *.xls file. In this Excel
TM file,
each overlapping category is separated into a column directly
related to the numerical set order from the master Venn diagram
output. The ‘Display Mode’ window for the Edwards Venn
visual display allows the user to replace the numerical categories
with specific textual representation of the input data points. The
VENNTURE program also contains a mouse ‘roll-over’
demonstration function for demonstration of the contents of
each of the specific sets in any format of Venn output. The
Edwards Venn image can then be simply exported graphically in
two different ways. One output option is to use the ‘Save As’
function to export the Edwards Venn image as an enhanced
metafile format graphics (*.emf) file. The second option is to use
the ‘Export’ function which instantly generates a Powerpoint
TM
file of the Edwards Venn. From this Powerpoint
TM file a high
resolution image (JPG, TIFF, PNG etc. ) can be generated using
the Powerpoint
TM ‘Save As’ function.
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Cellular Context Modification and Ligand Responses
The proteomic effects, in human SH-SY5Y neural cells, of our
previously-described chronic minimal peroxide (CMP) protocol
was assessed, using a panel of divergently CMP-regulated proteins
we had previously identified as specific markers of this modified
cellular state [14] (Figure 1). Application of the CMP protocol to
SH-SY5Y cells resulted in a significant upregulation of both lamin
(LAMN) and GIT2 (G protein-coupled receptor kinase interacting
ArfGAP 2: Figure 1A, B-C) and simultaneous, significant
downregulation of calmodulin (CALM) and calreticulin (CALR)
(Figure 1A, D-E). To assess the ability of the stable acetylcholine
analog (acetyl-b-methylcholine: MeCh) to stimulate signaling
activity in the SH-SY5Y cells, MeCh-mediated extracellular
signal-regulated kinase (ERK1/2) activation was assessed. In both
control-state and CMP-treated SH-SY5Y cells MeCh application
resulted in a dose-dependent increase in the activity status of
ERK1/2, as we have previously reported [14]. The basal level of
non-phosphorylated as well as phosphorylated ERK1/2 was not
significantly altered by the CMP protocol. From log dose-response
analysis, it was apparent that the alteration in cellular context
induced by CMP, caused an increase in the maximal response
(Rmax) to MeCh (Figure 1F). ERK1/2 activation responses to each
of the doses of MeCh tested (in both control- and CMP-state cells)
were effectively blocked by the pre-exposure of the SH-SY5Y cells
to the selective muscarinic G protein-coupled receptor antagonist
pirenzipine (10 mM, 30 minutes incubation prior to MeCh
exposure). In addition, no significant alteration of plasma
membrane muscarinic receptor expression was noted between
control and CMP conditions (Figure S1: [14]).
Phosphoprotein Extraction and Enrichment
Using a titanium dioxide-mediated phosphoprotein extraction
process [22], we were able to identify in SH-SY5Y cells the
presence of multiple phosphoproteins in the non-stimulated
control and peroxide-treated (CMP) state, as well as after the
Figure 1. Chronic minimal peroxide-mediated alteration of protein expression and ligand responses. (A) Representative western
immunoblot (IB) analysis of control (PBS-vehicle treated) or CMP treatment (7 days, 10 nM hydrogen peroxide treatment) effects upon cellular
expression of lamin A (LMNA), G protein-coupled receptor kinase interacting ArfGAP 2 (GIT2), calreticulin (CALR) and calmodulin (CALM1).
Quantification of CMP-mediated expression changes of LMNA (B), GIT2 (C), CALM1 (D) and CALR (E). Quantification was achieved as follows: western
blot relative absorbance units (x1000) minus background absorbance subtraction per square pixel: ((AU-B)/px
2). Quantification was performed using
ImageQuant 5.2 and statistical analysis was performed on three independent experiments using GraphPad Prism version 5.02 with a Student’s t-test
(p,0.05, *; p,0.01, **; p,0.001, ***). Data is represented as mean 6 standard error of mean (SEM). (F) Log dose-response curves for acetyl-b-
methycholine (MeCh)-mediated ERK1/2 activation in control (black circles) or CMP-treated (white square) cells. (G) Response-normalized MeCh ERK1/2
log dose-response curves. The maximal response for MeCh in each cellular context (control versus CMP) was considered to be 100% in each
circumstance. Each experimental point on the curves (fitted using sigmoidal dose-response functions in GraphPad Prism) represents the mean 6 SEM
of three independent experiments.
doi:10.1371/journal.pone.0036911.g001
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36911Figure 2. MeCh-induced protein phosphorylation in diverse cellular contexts. (A) Proportional diagrams illustrating the number of
specifically enriched and identified phosphoproteins, basally occurring, and induced by MeCh stimulation (10 nM to 100 mM) of control or CMP-
treated cells. (B) Selective protein immunoprecipitation (IP) and determination of MeCh-induced G protein-coupled receptor kinase interacting
ArfGAP 1 (GIT1) serine and threonine phosphorylation, with antisera immunoblot (IB), in MeCh-stimulated control-state SH-SY5Y cells. The associated
histogram (representing mean 6 SEM data from three independent immunoprecipitations) indicates the extent of immunoprecipitated protein
serine and threonine phosphorylation. Panels (C) and (D) indicate similar data from control-state cells for the MeCh-induced phosphorylation of G
protein regulated inducer of neurite outgrowth 1 (GPRIN1) and p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1). (E) Selective protein
immunoprecipitation and determination of MeCh-induced microtubule-associated protein 2 (MAP2) serine and threonine phosphorylation, with
antisera immunoblot, in MeCh-stimulated CMP-state SH-SY5Y cells. Panels (F) and (G) indicate similar data from CMP-state cells for the MeCh-induced
phosphorylation of reticulon-4 (RTN4) and GRB2-associated binding protein 2 (GAB2). Statistical analysis was performed on three independent
experiments using GraphPad Prism version 5.02 with a Student’s t-test (p,0.05, *; p,0.01, **; p,0.001, ***).
doi:10.1371/journal.pone.0036911.g002
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b-methylcholine (MeCh) in both cellular conditions (Protein
identifications listed in Supplementary Tables as follows: control
SH-SY5Y cells, non-stimulated-Table S1, 10 nM, 100 nM, 1 mM,
10 mM, 100mM MeCh-Tables S2, S3, S4, S5, S6 respectively;
CMP SH-SY5Y cells, non-stimulated-Table S7, 10 nM, 100 nM,
1 mM, 10 mM, 100 mM MeCh-Tables S8, S9, S10, S11, 12
respectively). Therefore, in our paradigm of ligand dose-responses
in diverse cellular contexts, we were able to generate six different
phosphoprotein datasets for each cellular context, i.e. control or
CMP-treated. The total number of phosphoproteins specifically
enriched and identified ($2 peptides required for identification of
each specific protein) for each of the MeCh doses applied, as well
as the proteins identified in the non-stimulated conditions for each
cell context (control or CMP) are depicted in Figure 2A. We
validated the presence of several protein serine or threonine
phosphorylations, stimulated by MeCh at multiple doses (10 nM,
100 nM, 1 mM), in both cell contexts (control, Figure 2B–D;
CMP, Figure 2E–G) using selective immunoprecipitation of the
target protein. The isolated target protein was then immuno-
blotted with specific anti-phosphoserine and anti-phosphothreo-
nine antisera. We did not assess the anti-phosphotyrosine content
of the selected proteins due to the considerably lower extent of this
form of protein phosphorylation typically observed with TiO2-
mediated enrichment techniques [22]. Using immunoblotting, we
verified our proteomic identification of the phosphorylation of G
protein-coupled receptor kinase interacting ArfGAP 1 (GIT1:
10 nM MeCh), G protein-regulated inducer of neurite outgrowth
1 (GPRIN1: 100 nM MeCh) and p21 protein (Cdc42/Rac)-
activated kinase 1 (PAK1: 1 mM MeCh) in control SH-SY5Y cells.
We also verified the MeCh-induced increase in phosphorylation,
identified with our TiO2-enrichment, of microtubule-associated
protein 2 (MAP2: 10 nM MeCh), reticulon-4 (RTN4: 100 nM
MeCh) and Grb2-associated binding protein 2 (GAB2: 1 mM
MeCh) in the CMP-treated SH-SY5Y cells.
VENNTURE Biological Data Analysis and Implementation
Our novel software program, VENNTURE, is constructed to
allow simple data (e.g. two to six datasets of any length) uploading
from commonly used software (Excel
TM), facilitate various forms
of dataset annotation display and allow simple exportation of
results to commonly used data and visual analytical tools (Excel
TM,
Powerpoint
TM) (Figure 3). Employing a classical Edwards ‘cog-
wheel’ approach, VENNTURE is able to accommodate between
2 and 6 individual datasets that generate an ever-increasing series
of Excel
TM spreadsheet data output, due to a rapid increase in
Venn diagram intersection complexity (Figure 4A). For our
primary application in this study, we have generated two groups
(control or CMP) of six separate datasets of proteins displaying a
ligand-mediated phosphorylated status which we then uploaded
into VENNTURE. We then employed VENNTURE for spread-
sheet analysis, visual analytical output and also for direct visual
appreciation of protein identification in each intersection using
VENNTURE’s ‘roll-over’ annotation option (Figure 4B).
VENNTURE-based Dose-specific Data Analysis
VENNTURE was used to rapidly separate and identify the
multiple subsections of the TiO2-enriched phosphoproteomic
data. The two input six-set phosphoprotein lists that we
employed for this assessment (using official human protein
symbols) are represented in Table S13 (control) and Table S14
(CMP). Using VENNTURE we were able to differentiate the
highly-complex, dose-dependent phosphoproteomic effects of
MeCh treatment, in both the control- and peroxide-treated
(CMP) state cells (Figure 5). In both cases when using
VENNTURE to separate out the specific subsets of phospho-
proteins, it became evident that different MeCh ligand doses, in
both cellular contexts employed (control- or CMP-state),
produced complex and largely ‘dose-unique’ phosphoproteomic
lists (Figure 5, control-state 5A, CMP-state 5B). Hence, many of
the MeCh-stimulated phosphoproteins were unique to a specific
log dose of the ligand (‘dose-unique’ protein sets are listed in
Table S15 (control) and Table S16 (CMP)). Such ‘dose-unique’
activity may suggest that these large differences in applied MeCh
dose interact preferentially with different stable ‘sub-states’ of the
same receptor [8,23–26]. However it is also possible that these
specific signaling profiles may also be influenced by the
differential availability of downstream signaling molecules, the
progressive activation of distinct stimulatory and autoregulatory
signaling events as well as micro temporal or kinetic variances in
ligand-receptor interactions induced by the different ligand doses.
Even with these potential complexities of receptor signaling,
using the unique capacities of VENNTURE, we have shown that
different doses of a single ligand, stimulating a unitary target
receptor, can activate largely distinct pools of phosphoproteins
across a log-dose response series. While phosphorylation is
potentially an important process in the alteration of individual
protein function, this information in itself may not be specifically
indicative of a given functional activity, as most physiological
actions involve interactions between multiple associated proteins.
We therefore applied Gene Ontology (GO) term analysis
(WebGestalt: http://bioinfo.vanderbilt.edu/webgestalt/ [27,28])
and canonical signaling pathway analysis (Ingenuity Pathway
Analysis: http://www.ingenuity.com/) to generate a higher order
of appreciation of the functional connections between our protein
sets, allowing us to further investigate the ‘dose-unique’ behavior
observed at the phosphoprotein level (Figure 5A, B). Data lists of
significantly populated GO term groups (n$2 proteins per group,
probability (p)#0.05) were created for each non-stimulated, or
MeCh-stimulated dose state (Tables S17, S18, S19, S20, S21,
S22 (control state) and Tables S23, S24, S25, S26, S27, S28
(CMP state)). For simple VENNTURE input, these dose-
dependent tables were then summarized (Table S29 (control)
and Table S30 (CMP)), and then subjected to six-way
VENNTURE separation (Figure 5C-control state, 5D-CMP
state). In an analogous manner to the phosphoprotein VENN-
TURE separations, we noticed a strong ‘dose-specific’ allocation
of the different GO-term groups for MeCh treatment of control
and peroxide-treated cells. This may suggest that with the
relatively specific dose-dependent protein phosphorylation, there
is also a dose-dependent variation in the activation of various
functional groups of proteins. The ‘dose-unique’ groups of
significantly enriched GO terms, for each cellular context, are
listed in Table S31 (control state) and Table S32 (CMP-state).
Significantly populated canonical signaling pathway matrices
(n$2 proteins per signaling pathway, p#0.05) were next created
for each non-stimulated, or MeCh-stimulated dose state in both
cellular contexts (Table S33 (control state) and Table S34 (CMP-
state)). The signaling pathway analysis was then subjected to six-
way VENNTURE separation. In a manner reminiscent to the
phosphoprotein and GO-term VENNTURE separations, we
noticed a strong dose-unique allocation of the different canonical
signaling pathways for MeCh treatment of control or peroxide-
treated CMP cells (Figure 5E and 5F respectively). The ‘dose-
unique’ groups of significantly enriched canonical signaling
pathways for each cellular context are listed in Table S35
(control-state) and Table S36 (CMP-state).
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Using VENNTURE, we were able to discern that many of the
functional outputs of MeCh-mediated muscarinic receptor stim-
ulation were strongly dose-dependent and also largely distinct at
each different dose. We further investigated how this signaling
diversity was specifically affected by dose between our two
experimental cellular contexts, i.e. control state versus CMP state.
We found that for phosphoproteins that were specific to MeCh-
stimulated VENNTURE sets (Figure 5A–B, Venn sets 2–62) a
similar percentage, in both cellular contexts, of these proteins were
found in ‘dose-unique’ sets only (36% control-state, 38% CMP-
sate). When analyzing the VENNTURE distribution of the GO
terms and canonical signaling pathways, we found a largely similar
distribution of factors to these ‘dose-unique’ Venn sets again for
both cellular contexts, i.e. approximately 36–39% of the MeCh-
stimulated GO term/signaling pathways (excluding phosphopro-
teins common to non-stimulated samples) were ‘dose-unique’ and
in the CMP groups 35–38% were ‘dose-unique’ (data not shown).
We then sub-divided these ‘dose-unique’ sectors into the respective
dose-specific proportions of phosphoproteins/GO terms/signaling
pathways (Figure 6). At the phosphoprotein level the percentage
bias of each dose within the total number of ‘dose-unique’
phosphoproteins was generally similar in the control state cells
(10 nM-15%, 100 nM-15%, 1 mM-21%, 10 mM-22%, 100 mM-
27%). In contrast, for the CMP-state cells, a reduction in the
percentage of phosphoproteins unique to the lower doses was
observed (10 nM-7%, 100 nM-11%: Figure 6-Protein) compared
to control-state cells. As proteins can possess multiple functions,
and therefore could be grouped into several GO term groups or
signaling pathways, it would be expected that a divergence in
relative dose-specific proportions in these functional groups would
occur. A stark contrast was observed with respect to the ‘dose-
unique’ profile of GO term groups between the control and CMP-
state cells. The relative proportions of ‘dose-unique’ GO term
groups were roughly similar in control-state cells (Figure 6-GO
term). However in CMP cells more than half (54%) of the total
number of ‘dose-unique’ significantly-populated GO term groups
were found at the 100 mM dose. Concomitantly, a large reduction
of the low-MeCh dose-specific GO term groups was observed
(10 nM-4% in CMP cells versus 24% in control cells: Figure 6-GO
term). At the signaling pathway level, the dose-related functional
output differences were even more diverse between control and
CMP-state cells. In each cell context, one specific MeCh dose
appeared to generate the most extensive signaling repertoire, i.e.
ability to stimulate many forms of potential signaling cascades.
Such activity is indicated by the largest numbers of significantly-
populated signaling pathways populated by protein phosphoryla-
tion events induced by a specific ligand dose. In the control state
Figure 3. VENNTURE data input and output scenarios. Simplistic data (two set analysis) input into VENNTURE is achieved using an Excel
TM
input file. The data representation type can be selected using a drop-down menu for numerical set analysis, set order demonstration for eventual
output and also textual set content. The resultant set data output can be directly generated for PowerPoint
TM (Venn diagram) and Excel
TM (dataset
descriptions).
doi:10.1371/journal.pone.0036911.g003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36911Figure 4. Multiple set VENNTURE data input. (A) In addition to simplistic data (two set analysis) input into VENNTURE, the program is flexible in
that it can accept up to 6 input sets. With increasing set input, from Excel
TM files, is a concomitant elevation in diagram complexity along with the
eventual dataset output in column format in an Excel
TM spreadsheet. With increasing numbers of input sets VENNTURE automatically alters its Venn
output and organizes the eventual column display in Excel
TM. (B) Basic flow-chart for use of VENNTURE in the experimental investigation of the log
dose-response of MeCh-induced phosphoproteomic changes in multiple cellular contexts. VENNTURE data output can be used for diagram
generation (PowerPoint
TM output), direct inspection Venn intersection contents (direct roll-over reveal option) and output for mathematical
calculation (Excel
TM).
doi:10.1371/journal.pone.0036911.g004
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this dose was 10 mM MeCh (Figure 6-Signaling pathway). No
significant signaling pathways were populated by the lowest MeCh
dose (10 nM) in the CMP-state cells, while 11% of total ‘dose-
unique’ signaling pathways were stimulated specifically by 10 nM
MeCh in the control-state cells. Such ligand dose- and cellular
context-dependent alteration of receptor signaling profiles may be
suggestive of altered populations of muscarinic receptors in stable
isomeric conformations that are ‘hard-wired’ into specific signaling
paradigms [8,9,13,29,30]. Reinforcing the considerable differences
observed between ‘dose-unique’ proportions of phosphoprotein/
GO term/signaling pathways in the control- or CMP-state cells,
we found that in a dose-by-dose comparison there was minimal
cross-over between proteins/GO terms/signaling pathways be-
tween these two cell contexts (Figure 7A). Combining and
summarizing the functional annotation information (both GO
term and canonical signaling pathway enrichment) for each dose
of MeCh, it was apparent that distinct potential functional
outcomes were generated by different MeCh doses within a single
cellular context (Figure 7B). Moreover, in a dose-to-dose
comparison, between cellular context models, profoundly distinct
signaling outcomes were generated between these two cellular
states (control versus CMP: Figure 7B). This may suggest that the
functional outcomes of receptor stimulation may be considerably
disrupted by the multiple proteomic/genomic alterations induced
by CMP treatment which, in-part, mimics cell aging [14]. While
the CMP treatment may affect dynamic responses to receptor
stimulation, it clearly also exerts multiple and differential effects
upon steady state (non-stimulated experiments) protein expression
as well (Figure 7B: Tables S17, S23, S33, S34). Hence in non-
stimulated control-state cells cyclin-dependent kinases signaling
was evident, while fatty acid synthesis and apoptotic mechanisms were
Figure 5. VENNTURE analysis of log dose-response ligand data in diverse cellular contexts. VENNTURE Venn diagram set distribution
analysis (1–63 set intersections) of extracted phosphoproteins in the stimulated or non-stimulated SH-SY5Y cells in the control state (‘Control’ - A) or
peroxide-treated state (‘CMP’ - B). Specific column color coding is as follows: blue - phosphoproteins unique to non-stimulated state only, red –
phosphoproteins unique to a specific MeCh stimulation dose only; grey – phosphoproteins common to multiple MeCh doses but not present in the
non-stimulated set; black – phosphoproteins common to multiple MeCh doses also present in the non-stimulated set; green – phosphoproteins
common to all doses and the non-stimulated set. GO term enrichment analysis was performed using the initial phosphoprotein sets from cells in the
control or CMP-treated states. The significantly enriched (p#0.05) GO term groups for each non-stimulated or MeCh-stimulated set were then
separated using VENNTURE in a similar manner to the actual phosphoprotein identifications. VENNTURE Venn diagram set distribution analysis of GO
term groups significantly populated by the extracted phosphoproteins in the control state (C) or CMP-state (D) cells is depicted. Color-coding of the
histogram is as described previously. Canonical signaling pathway enrichment analysis was also performed using the initial phosphoprotein sets from
cells in the control or CMP-treated states. The significantly enriched (p#0.05) canonical signaling pathways for each non-stimulated or MeCh-
stimulated set were then separated using VENNTURE in a similar manner to the actual phosphoprotein identifications. VENNTURE Venn diagram set
distribution analysis of the canonical signaling pathways significantly populated by the extracted phosphoproteins in the control state (E) or CMP-
state (F) cells is depicted.
doi:10.1371/journal.pone.0036911.g005
Figure 6. Dose-dependent distribution of MeCh-stimulated signaling activity in diverse cellular contexts. Proportional diagrams
representing the relative distribution of phosphoproteins (Proteins)/GO term groups (GO term)/signaling pathways (Signaling Pathway) unique to an
individual stimulating MeCh dose (color coded) in either cellular context (control or CMP).
doi:10.1371/journal.pone.0036911.g006
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PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e36911Figure 7. Cellular context modification of downstream receptor signaling activity in SH-SY5Y cells. (A) Comparison of phosphoprotein/
GO term group/canonical signaling pathway activation in the non-stimulated (blue circle) and multiple MeCh-stimulated conditions (red circles) in
either control-state (solid line) or CMP-state (dashed lines) SH-SY5Y cells. (B) Summary of potential non-stimulated and MeCh-induced signaling
functionality (aggregate of highest-scoring GO-term group and canonical signaling pathway enrichments) in a dose-dependent manner compared
between control-state or CMP-state cells.
doi:10.1371/journal.pone.0036911.g007
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respect to the dynamic signaling responses with 10 nM MeCh
stimulation of control cells, an output related to spindle kinetics,
molecular motor function and energy regulatory pathways was predicted,
while similar MeCh-stimulation of CMP-treated SH-SY5Y cells
suggested only effects upon cell motility. With 100 nM MeCh
stimulation of control state cells, stimulation of microtubule-associated
protein kinases, DNA regulatory behavior and neuroprotective kinase
(phosphoinositide-3-kinase) signaling was predicted, while a
distinct output phenotype was present in CMP cells, i.e.
stimulation of synaptic signaling and endocytic activity was predicted.
With 1 mM stimulation, again a strong divergence of signaling
activity for MeCh was seen between control and CMP cellular
states. In control cells, at a 1 mM dose, stimulation of histone
modifying activity and mRNA processing was observed, while in CMP-
cells signaling activity appeared to center more upon neuronal
filament/stress fiber modification, amine metabolism and neurotrophic
signaling. With 10 mM stimulation, MeCh-stimulation of control-
state cells regulated nucleotide-dependent kinase activity as well as
signaling involved in pro-excitatory neurotransmission. The 10 mM
stimulation of CMP-state cells however was less phenotypically
robust and was instead linked to cation binding, genomic stabilization
and lipid-mediated stress signaling. At the highest dose of MeCh
employed (100 mM), stimulation of stress fiber, proteasomal and gene
regulatory activity was observed in control-state cells, while in CMP-
state cells we noted a strong neuronal differentiation, metabolic and
biosynthetic bias of signaling (Figure 7B: Tables S31, S32-GO terms;
S35, S36-canonical signaling pathways).
Discussion
Our novel program, VENNTURE, allows the facile simulta-
neous analysis of multiple large and complex pharmacological
datasets. Using this program we have shown, with a high volume of
complexinput data,thatVENNTUREisabletogeneratebiological
datasets that have aided the comprehension of higher orders of
signaling behavior in ligand-receptor systems. Ligand-receptor
interactions at GPCRs are perhaps one of the most important
events in clinical and molecular pharmacology, as more than half of
the current pharmacopeia is populated by GPCR-targeted drugs
[8,16]. For many years these molecular interactions were consid-
ered to be mechanistically relatively simple, e.g. the agonist-driven
receptor structural change concept was described as the ‘two-state’
model of receptor activation. This model eventually was superseded
by the ‘ternary complex model’ [31] that identified a third stable
receptor conformation that was a ‘transition state’ between R and
R* [32]. With experimental advances it has become clear that
GPCR activity is even more complicated then ever imagined. i.e.
GPCRs can demonstrate higher-order signaling complex assembly,
downstream signaling promiscuity and signal-selective ligand
behavior [33–41]. As both ligand interaction with GPCRs [23–
25,42–44] and the eventual downstream signaling induced by
receptor activation [26,45–49], are likely to be controlled by
multiple cellular factors, such as stress-state or the presence of
intracellular scaffolding proteins, it is imperative that our under-
standing of how these changes affect dose-dependent GPCR
pharmacology be included in our drug discovery methodologies.
Using VENNTURE we were able to distinguish and investigate
highly nuanced dose- and context-specific ligand-receptor behavior.
The ability to generate such an in-depth appreciation of the ligand-
receptor signaling profile, in multiple cellular states, may be initially
employed to greatly enhance the efficiency and accuracy of drug
design. The ability to understand the changes in drug response
profiles in different pharmacogenomic backgrounds, e.g. controland
peroxide-treated states [14], may greatly assist in the generation of
contextually-specific pharmacological agents. The functional ex-
perimental example demonstrated in this study outlines one
potential use of VENNTURE, however, this novel program can
be utilized for any research purpose that requires simultaneous
comparison of multiple large data sets.
The specific application of our novel VENNTURE program to
these extremely complex sets of signaling data allowed the facile
elucidation of the subtle effects that environmental perturbations
can exert upon dose-dependent ligand actions. Such findings may
have profound implications for novel therapeutic design, as both
the dose-specificity of signaling quality and its modulation by
altered cellular context may be extremely important factors to
consider for future GPCR drug discovery [8,9,14,50].
The VENNTURE application can be used on any personal
computer using any Windows
TM XP or higher Windows
TM-
based system. To make VENNTURE as accessible to as many
potential users we have specifically tailored the program to
employ the most commonly used MS-Office platforms, e.g.
Excel
TM and Powerpoint
TM. While the MS-Office suite is the
most widely-used platform in the world, we appreciate that non-
MS Office users also present an important user-base, therefore
we intend to develop VENNTURE for use with non-MS-Office
or OpenSource (e.g. OpenOffice) software platforms. Presently
VENNTURE version 1.1.0.2 can be accessed freely at the
National Institute on Aging (http://www.nia.nih.gov). There are
some potential aspects to VENNTURE that can be expanded
upon in the future, such as an elevation of dataset handling
beyond only six sets. However, while VENNTURE is able to
theoretically model an infinite number of data sets, the visual
presentation of more than eight data sets ultimately becomes too
visually complicated to extract actionable data. VENNTURE
presents significant advancements in visual presentation, data
analysis, and user-friendliness over currently available Venn
diagram programs and it will be a useful tool for the analysis of
complex datasets in pharmacology, genomics, and bioinformatics
research fields.
Supporting Information
Figure S1 Effects of chronic minimal peroxide (CMP)
exposure upon muscarinic receptor activity. (A) Twenty
micrograms of SH-SY5Y whole-cell lysate resolved using an SDS-
polyacrylamide gel and then stained with coomassie for total
protein detection (MW-molecular weight markers). Associated
histogram and representative western blot indicate minimal
alteration of m1-muscarinic acetylcholine receptor (m1AchR:
antisera obtained from Sigma-Aldrich, St. Louis MO) expression
(quantified as 10006 arbitrary intensity units (AU) minus
background (B) intensity per square pixel (10006(AU-B)/px
2))
with application of CMP protocol (expression controlled using
whole-cell coomassie stain). (B) Blockade of acetyl-b-methylcholine
(MeCh)-mediated ERK1/2 activation in control-state cells with a
30 minute pre-exposure of cells to the muscarinic receptor
antagonist pirenzipine (10 mM: gray shaded bars). (C) Blockade
of MeCh-mediated ERK1/2 activation in CMP-state cells with a
30 minute pre-exposure of cells to the muscarinic receptor
antagonist pirenzipine (10 mM: shaded bars).
(TIF)
Table S1 Phosphoproteins extracted from un-stimulated con-
trol-state human neuroblastoma SH-SY5Y cells. For each
successfully identified protein official symbol, Uniprot accession
code and number of peptides recovered are indicated.
(DOC)
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control-state human neuroblastoma SH-SY5Y cells. For each
successfully identified protein official symbol, Uniprot accession
code and number of peptides recovered are indicated.
(DOC)
Table S3 Phosphoproteins extracted from 100 nM MeCh-
treated control-state human neuroblastoma SH-SY5Y cells. For
each successfully identified protein official symbol, Uniprot
accession code and number of peptides recovered are indicated.
(DOC)
Table S4 Phosphoproteins extracted from 1 mM MeCh-treated
control-state human neuroblastoma SH-SY5Y cells. For each
successfully identified protein official symbol, Uniprot accession
code and number of peptides recovered are indicated.
(DOC)
Table S5 Phosphoproteins extracted from 10 mM MeCh-treated
control-state human neuroblastoma SH-SY5Y cells. For each
successfully identified protein official symbol, Uniprot accession
code and number of peptides recovered are indicated.
(DOC)
Table S6 Phosphoproteins extracted from 100 mM MeCh-
treated control-state human neuroblastoma SH-SY5Y cells. For
each successfully identified protein official symbol, Uniprot
accession code and number of peptides recovered are indicated.
(DOC)
Table S7 Phosphoproteins extracted from untreated chronic
minimal peroxide (CMP)-state human neuroblastoma SH-SY5Y
cells. For each successfully identified protein official symbol, Uniprot
accession code and number of peptides recovered are indicated.
(DOC)
Table S8 Phosphoproteins extracted from 10 nM MeCh-
stimulated chronic minimal peroxide (CMP)-state human neuro-
blastoma SH-SY5Y cells. For each successfully identified protein
official symbol, Uniprot accession code and number of peptides
recovered are indicated.
(DOC)
Table S9 Phosphoproteins extracted from 100 nM MeCh-
stimulated chronic minimal peroxide (CMP)-state human neuro-
blastoma SH-SY5Y cells. For each successfully identified protein
official symbol, Uniprot accession code and number of peptides
recovered are indicated.
(DOC)
Table S10 Phosphoproteins extracted from 1 mM MeCh-
stimulated chronic minimal peroxide (CMP)-state human neuro-
blastoma SH-SY5Y cells. For each successfully identified protein
official symbol, Uniprot accession code and number of peptides
recovered are indicated.
(DOC)
Table S11 Phosphoproteins extracted from 10 mM MeCh-
stimulated chronic minimal peroxide (CMP)-state human neuro-
blastoma SH-SY5Y cells. For each successfully identified protein
official symbol, Uniprot accession code and number of peptides
recovered are indicated.
(DOC)
Table S12 Phosphoproteins extracted from 100 mM MeCh-
stimulated chronic minimal peroxide (CMP)-state human neuro-
blastoma SH-SY5Y cells. For each successfully identified protein
official symbol, Uniprot accession code and number of peptides
recovered are indicated.
(DOC)
Table S13 Dose-dependent acetyl-b-methylcholine-stimulated
phosphoproteins in control-state human neuroblastoma SH-
SY5Y cells. Ligand stimulation with acetyl-b-methylcholine
(MeCh) was for 15 minutes before cell lysate protein extraction
and titanium dioxide-mediated purification.
(DOC)
Table S14 Dose-dependent acetyl-b-methylcholine-stimulated
phosphoproteins in CMP-state human neuroblastoma SH-SY5Y
cells. Ligand stimulation, performed after pre-treatment for seven
days with 10 nM continuous hydrogen peroxide treatment (CMP
protocol), with acetyl-b-methylcholine (MeCh) was for 15 minutes
before cell lysate protein extraction and titanium dioxide-mediated
purification.
(DOC)
Table S15 Dose-unique MeCh-stimulated protein phosphoryla-
tion in control-state SH-SY5Y cells. The proteins uniquely
phosphorylated at the specified MeCh dose only in control-state
SH-SY5Y cells are indicated by their protein symbol as well as
Uniprot accession number.
(DOC)
Table S16 Dose-unique MeCh-stimulated protein phosphoryla-
tion in CMP-state SH-SY5Y cells. The proteins uniquely
phosphorylated at the specified MeCh dose only in CMP-state
SH-SY5Y cells are indicated by their protein symbol as well as
Uniprot accession number.
(DOC)
Table S17 GO term groups populated by extracted phospho-
proteins in non-stimulated control-state SH-SY5Y cells. GO term
groups were considered enriched only if at least two proteins were
present in each group and with a probability of #0.05. Hybrid
GO term group scores were generated by multiplication of the GO
term group enrichment score with the negative log10 of the
probability result.
(DOC)
Table S18 GO term groups populated by extracted phospho-
proteins in 10 nM MeCh-stimulated control-state SH-SY5Y cells.
GO term groups were considered enriched only if at least two
proteins were present in each group and with a probability of
#0.05. Hybrid GO term group scores were generated by
multiplication of the GO term group enrichment score with the
negative log10 of the probability result.
(DOC)
Table S19 GO term groups populated by extracted phospho-
proteins in 100 nM MeCh-stimulated control-state SH-SY5Y
cells. GO term groups were considered enriched only if at least
two proteins were present in each group and with a probability of
#0.05. Hybrid GO term group scores were generated by
multiplication of the GO term group enrichment score with the
negative log10 of the probability result.
(DOC)
Table S20 GO term groups populated by extracted phospho-
proteins in 1 mM MeCh-stimulated control-state SH-SY5Y cells.
GO term groups were considered enriched only if at least two
proteins were present in each group and with a probability of
#0.05. Hybrid GO term group scores were generated by
multiplication of the GO term group enrichment score with the
negative log10 of the probability result.
(DOC)
Table S21 GO term groups populated by extracted phospho-
proteins in 10 mM MeCh-stimulated control-state SH-SY5Y cells.
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proteins were present in each group and with a probability of
#0.05. Hybrid GO term group scores were generated by
multiplication of the GO term group enrichment score with the
negative log10 of the probability result.
(DOC)
Table S22 GO term groups populated by extracted phospho-
proteins in 100 mM MeCh-stimulated control-state SH-SY5Y
cells. GO term groups were considered enriched only if at least
two proteins were present in each group and with a probability of
#0.05. Hybrid GO term group scores were generated by
multiplication of the GO term group enrichment score with the
negative log10 of the probability result.
(DOC)
Table S23 GO term groups populated by extracted phosphopro-
teins in non-stimulated CMP-state SH-SY5Y cells. GO term groups
were considered enriched only if at least two proteins were present in
each group and with a probability of #0.05. Hybrid GO term group
scores were generated by multiplication of the GO term group
enrichment score with the negative log10 of the probability result.
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